Assenagon Asset Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,079
Closed -$79.2K 1440
2024
Q2
$79.2K Sell
5,079
-727
-13% -$12.2K ﹤0.01% 1394
2024
Q1
$127K Buy
5,806
+3,377
+139% +$75K ﹤0.01% 1341
2023
Q4
$47K Buy
+2,429
New +$44.3K ﹤0.01% 1389
2022
Q3
Sell
-1,127
Closed -$62K 1492
2022
Q2
$62K Sell
1,127
-4,582
-80% -$169K ﹤0.01% 1420
2022
Q1
$212K Buy
+5,709
New +$204K ﹤0.01% 1347
2021
Q2
Sell
-6,183
Closed -$342K 1357
2021
Q1
$342K Buy
+6,183
New +$376K ﹤0.01% 1087

Other funds holding OPTN

Assenagon Asset Management's OPTN Position: Q3 2024 in Review

Assenagon Asset Management sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 5,079 shares — an estimated $79.2K sold.

Assenagon Asset Management first reported a position in OPTN in Q1 2021 and held it in 6 quarters. The position peaked at $342K in Q1 2021. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Assenagon Asset Management reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 5,079 OptiNose shares in Q3 2024, an estimated $79.2K.
  • Assenagon Asset Management first reported a position in OptiNose in Q1 2021 and held it in 6 quarters.
  • Assenagon Asset Management's OptiNose position peaked at $342K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Assenagon Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.